UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 493

Sortiert nach

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2019-12, Vol.30 (12), p.1856-1883

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study

Annals of oncology, 2015-10, Vol.26 (10), p.2119-2125

2015

Link zum Volltext

Verfügbarkeit prüfen

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

Annals of oncology, 2022-07, Vol.33 (7), p.674-684

2022

Link zum Volltext

Verfügbarkeit prüfen

SP-049: Optimisation of Radio-Isotope Treatments

Radiotherapy and oncology, 2013-02, Vol.106, p.S20-S20

Leboulleux, S

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy

The journal of clinical endocrinology and metabolism, 2006-08, Vol.91 (8), p.2892-2899

2006

Link zum Volltext

Verfügbarkeit prüfen

Pour les cancers thyroïdiens

Annales d'endocrinologie, 2016-09, Vol.77 (4), p.247-247

Leboulleux, S., Dr

2016

Link zum Volltext

Verfügbarkeit prüfen

Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma

Endocrine-related cancer, 2015-06, Vol.22 (3), p.289-298

2015

Link zum Volltext

Verfügbarkeit prüfen

Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?

Endocrine-related cancer, 2011-02, Vol.18 (1), p.159-169

2011

Link zum Volltext

Verfügbarkeit prüfen

Somatic RAS Mutations Occur in a Large Proportion of Sporadic RET-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon

The journal of clinical endocrinology and metabolism, 2012-10, Vol.97 (10), p.E2031-E2035

2012

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2016-07, Vol.101 (7), p.2733-2741

2016

Link zum Volltext

Verfügbarkeit prüfen

Consequences of atmospheric contamination by radioiodine: the Chernobyl and Fukushima accidents

Endocrine, 2021-02, Vol.71 (2), p.298-309

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma

The journal of clinical endocrinology and metabolism, 2013-12, Vol.98 (12), p.4759-4767

2013

Link zum Volltext

Verfügbarkeit prüfen

Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level

Endocrine-related cancer, 2011-04, Vol.18 (2), p.R29-R40

2011

Link zum Volltext

Verfügbarkeit prüfen

Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

European journal of endocrinology, 2010-06, Vol.162 (6), p.1147

2010

Link zum Volltext

Verfügbarkeit prüfen

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection

European journal of endocrinology, 2013-09, Vol.169 (3), p.263

2013

Link zum Volltext

Verfügbarkeit prüfen

Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.149-158

2020

Link zum Volltext

Verfügbarkeit prüfen

Patient-specific biokinetics and hybrid 2D/3D approach integration in OEDIPE software: Application to radioiodine therapy

Physica medica, 2023-09, Vol.113, p.102462-102462, Article 102462

2023

Link zum Volltext

Verfügbarkeit prüfen

Thermal-ablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma

European journal of radiology, 2019-10, Vol.119, p.108650-108650, Article 108650

2019

Link zum Volltext

Verfügbarkeit prüfen

SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithms

Annales d'endocrinologie, 2022-12, Vol.83 (6), p.440-453

2022

Link zum Volltext

Verfügbarkeit prüfen

Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study

The journal of clinical endocrinology and metabolism, 2006-03, Vol.91 (3), p.926-932

2006

Link zum Volltext

Verfügbarkeit prüfen

Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation

European journal of endocrinology, 2013-11, Vol.169 (5), p.689

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the Incremental Value of Recombinant Thyrotropin Stimulation before 2-[18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Imaging to Localize Residual Differentiated Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1310-1316

2009

Link zum Volltext

Verfügbarkeit prüfen

Locally unresectable differentiated thyroid cancer: outcomes and perspectives

Endocrine, 2020-07, Vol.69 (1), p.133-141

2020

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and Prognostic Value of 18-Fluorodeoxyglucose Positron Emission Tomography in Adrenocortical Carcinoma: A Prospective Comparison with Computed Tomography

The journal of clinical endocrinology and metabolism, 2006-03, Vol.91 (3), p.920-925

2006

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Thermal-ablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma” [Eur. J. Radiol. 119 (2019) 108650]

European journal of radiology, 2019-12, Vol.121, p.108693-108693, Article 108693

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 493

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(453)
Mit Volltextzugriff
(428)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(238)
Life Sciences & Biomedicine
(232)
Humans
(223)
Endocrinology & Metabolism
(150)
Female
(146)
Male
(133)
Adult
(130)
Middle Aged
(130)
Aged
(108)
Biological And Medical Sciences
(87)
Medical Sciences
(85)
Oncology
(77)
Endocrinopathies
(55)
Thyroid Neoplasms - Pathology
(55)
Retrospective Studies
(53)
Adolescent
(51)
Internal Medicine
(49)
Thyroid Cancer
(47)
Prognosis
(45)
Fundamental And Applied Biological Sciences. Psychology
(44)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

SP-049: Optimisation of Radio-Isotope Treatments

Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy

Pour les cancers thyroïdiens

Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma

Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?

Somatic RAS Mutations Occur in a Large Proportion of Sporadic RET-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon

Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer

Consequences of atmospheric contamination by radioiodine: the Chernobyl and Fukushima accidents

Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma

Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level

Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection

Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms

Patient-specific biokinetics and hybrid 2D/3D approach integration in OEDIPE software: Application to radioiodine therapy

Thermal-ablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma

SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithms

Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study

Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation

Assessment of the Incremental Value of Recombinant Thyrotropin Stimulation before 2-[18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Imaging to Localize Residual Differentiated Thyroid Cancer

Locally unresectable differentiated thyroid cancer: outcomes and perspectives

Diagnostic and Prognostic Value of 18-Fluorodeoxyglucose Positron Emission Tomography in Adrenocortical Carcinoma: A Prospective Comparison with Computed Tomography

Corrigendum to “Thermal-ablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma” [Eur. J. Radiol. 119 (2019) 108650]

Suchergebnisse filtern